Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1881614873
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
200 Medical Plaza, #365,530,420,120
Los Angeles, CA, 90095
Phone (310) 825-6301
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
1,288 services
Medicare patients, 2024
59
Average age 71
Drug cost, 2024
$4.4M
431 prescriptions
Company payments, 2025
$112
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil P Shah was code 99215 (office e&m - established), 149 times for 56 patients. In total Neil P Shah billed 1,288 services in 9 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 149 | 56 | $108.02 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 100 | 54 | $14.37 | $1,437 |
By year: 2022 $15K for 127 services; 2023 $13K for 123 services; 2024 $19K for 1,288 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neil P Shah prescribed most often to Medicare patients was Sprycel (Dasatinib), with 204 prescriptions and refills. In total Neil P Shah wrote 431 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sprycel Dasatinib | 204 | 218 | 28 | $1.7M |
| Scemblix Asciminib Hydrochloride | 121 | 128 | 16 | $2.1M |
| Bosulif Bosutinib | 24 | 24 | Under 11 | $228K |
| Hydroxyurea Generic | 21 | 37 | Under 11 | $951 |
| Tasigna Nilotinib Hcl | 20 | 20 | Under 11 | $206K |
Brand drugs: 377 claims; generic drugs: 54 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neil P Shah $112 ($112 in general payments such as food, travel and fees) from 1 company. The largest payer was AstraZeneca Pharmaceuticals LP with $112.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.